Company / Current Liabilities per Share
Amgen Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$47.47
FY2025
5-year range
$21.07 / $47.47
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#3 of 212
Health Care
What the data says
Among 212 Health Care companies, Amgen is in the bottom 1% for current liabilities per share. Current Liabilities per Share has increased for 5 consecutive years, from $19.70 in FY2020 to $47.47 in FY2025.
Based on SEC 10-K filings.
47.47 in FY2025 with a 5-year CAGR of +19.2%. Ranks 3rd among 212 companies in Health Care.
Increased from $34.44 to $47.47 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +19.1%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
+203.5% above sector average
Key checks
Key Insights
- Amgen's current liabilities per share has grown for 5 consecutive years.
- In FY2025, current liabilities per share increased 10.0% year-over-year.
- Ranks #3 out of 212 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.47 | +10.0% |
| FY2024 | $43.14 | +25.3% |
| FY2023 | $34.44 | +22.6% |
| FY2022 | $28.10 | +33.4% |
| FY2021 | $21.07 | +6.9% |
| FY2020 | $19.70 | -3.3% |
| FY2019 | $20.39 | +9.2% |
| FY2018 | $18.68 | +52.8% |
| FY2017 | $12.22 | -17.8% |
| FY2016 | $14.86 | +30.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026